In addition, studies in our laboratory have characterized CAIX and CAXII as robust pHi-regulating enzymes and have provided evidence that both CAIX and CAXII hold potential as new anti-cancer targets (Chiche et al., 2010a). This evidence concerns the gene CA12 and cancer.